We Aspire to Cure CancerTM
NINLARO (ixazomib) capsules now approved in the U.S.
At Takeda Oncology, the oncology business unit brand of Takeda Pharmaceutical Company Limited, we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.